Norges Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,261,026
| Closed | -$29M | – | 1075 |
|
|
2025
Q4 | $29M | Buy |
+1,261,026
| New | +$41.5M | ﹤0.01% | 1175 |
|
|
2025
Q3 | – | Sell |
-983,638
| Closed | -$35.8M | – | 1199 |
|
|
2025
Q2 | $35.8M | Hold |
983,638
| – | – | ﹤0.01% | 1071 |
|
|
2025
Q1 | $35.6M | Buy |
983,638
+21,844
| +2% | +$909K | 0.01% | 1068 |
|
|
2024
Q4 | $40.5M | Buy |
961,794
+21,168
| +2% | +$1.05M | 0.01% | 1042 |
|
|
2024
Q3 | $52.3M | Sell |
940,626
-61,837
| -6% | -$3.15M | 0.01% | 953 |
|
|
2024
Q2 | $41.2M | Buy |
1,002,463
+203,959
| +26% | +$8.71M | 0.01% | 978 |
|
|
2024
Q1 | $37.3M | Buy |
798,504
+27,998
| +4% | +$1.32M | 0.01% | 1065 |
|
|
2023
Q4 | $36.8M | Buy |
770,506
+172,418
| +29% | +$6.68M | 0.01% | 1043 |
|
|
2023
Q3 | $21.3M | Hold |
598,088
| – | – | ﹤0.01% | 1209 |
|
|
2023
Q2 | $27.6M | Sell |
598,088
-75,604
| -11% | -$3.51M | 0.01% | 1116 |
|
|
2023
Q1 | $27M | Sell |
673,692
-49,940
| -7% | -$2.14M | 0.01% | 1130 |
|
|
2022
Q4 | $33.5M | Sell |
723,632
-41,488
| -5% | -$1.63M | 0.01% | 1007 |
|
|
2022
Q3 | $31.7M | Buy |
765,120
+95,850
| +14% | +$4.93M | 0.01% | 974 |
|
|
2022
Q2 | $39.9M | Buy |
669,270
+6,594
| +1% | +$406K | 0.01% | 878 |
|
|
2022
Q1 | $48.1M | Buy |
662,676
+41,100
| +7% | +$2.86M | 0.01% | 905 |
|
|
2021
Q4 | $52.3M | Buy |
621,576
+59,038
| +10% | +$4.8M | 0.01% | 914 |
|
|
2021
Q3 | $50.7M | Sell |
562,538
-41,800
| -7% | -$3.78M | 0.01% | 917 |
|
|
2021
Q2 | $57.6M | Buy |
604,338
+59,885
| +11% | +$6.24M | 0.01% | 886 |
|
|
2021
Q1 | $62M | Sell |
544,453
-14,990
| -3% | -$2.04M | 0.01% | 855 |
|
|
2020
Q4 | $77.4M | Buy |
559,443
+84,621
| +18% | +$10M | 0.02% | 715 |
|
|
2020
Q3 | $39M | Sell |
474,822
-532
| -0.1% | -$44.1K | 0.01% | 977 |
|
|
2020
Q2 | $37.2M | Sell |
475,354
-37,210
| -7% | -$2.46M | 0.01% | 1043 |
|
|
2020
Q1 | $22.8M | Hold |
512,564
| – | – | 0.01% | 1164 |
|
|
2019
Q4 | $21.9M | Hold |
512,564
| – | – | 0.01% | 1474 |
|
|
2019
Q3 | $21.9M | Buy |
512,564
+28,058
| +6% | +$1.52M | 0.01% | 1429 |
|
|
2019
Q2 | $30.8M | Buy |
484,506
+43,999
| +10% | +$2.8M | 0.01% | 1212 |
|
|
2019
Q1 | $30.6M | Buy |
440,507
+71,429
| +19% | +$4.08M | 0.01% | 1197 |
|
|
2018
Q4 | $16M | Buy |
369,078
+43,564
| +13% | +$2.38M | 0.01% | 1532 |
|
|
2018
Q3 | $24.9M | Sell |
325,514
-230,880
| -41% | -$18.8M | 0.01% | 1399 |
|
|
2018
Q2 | $42.8M | Sell |
556,394
-295,859
| -35% | -$19.1M | 0.01% | 960 |
|
|
2018
Q1 | $43.5M | Buy |
852,253
+323,723
| +61% | +$16.3M | 0.02% | 882 |
|
|
2017
Q4 | $24.5M | Hold |
528,530
| – | – | 0.01% | 1339 |
|
|
2017
Q3 | $28.1M | Hold |
528,530
| – | – | 0.01% | 1209 |
|
|
2017
Q2 | $32.8M | Buy |
528,530
+79,815
| +18% | +$4.81M | 0.01% | 1041 |
|
|
2017
Q1 | $30.4M | Sell |
448,715
-73,500
| -14% | -$5.6M | 0.01% | 1076 |
|
|
2016
Q4 | $36.7M | Hold |
522,215
| – | – | 0.02% | 869 |
|
|
2016
Q3 | $35.4M | Buy |
522,215
+230,426
| +79% | +$14.7M | 0.02% | 828 |
|
|
2016
Q2 | $14.3M | Sell |
291,789
-14,800
| -5% | -$957K | 0.01% | 1409 |
|
|
2016
Q1 | $19.4M | Hold |
306,589
| – | – | 0.01% | 1175 |
|
|
2015
Q4 | $34.4M | Buy |
306,589
+11,367
| +4% | +$1.14M | 0.02% | 802 |
|
|
2015
Q3 | $28.4M | Buy |
295,222
+49,577
| +20% | +$5.68M | 0.01% | 903 |
|
|
2015
Q2 | $25.2M | Buy |
245,645
+223,645
| +1,017% | +$17.4M | 0.01% | 1053 |
|
|
2015
Q1 | $1.37M | Buy |
+22,000
| New | +$1.22M | ﹤0.01% | 2126 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG